Verisk said Q2 2025 revenue was $773 million, up 7.8%, and net income was $253 million, down 17.7%. The company cited net gains in the prior year period related to sales of its healthcare and specialized market businesses and the early extinguishment of debt as factors in the net income decrease.

1. 01

   Verisk said Q2 2025 revenue was $773 million, up 7.8%, and net income was $253 million, down 17.7%. The company cited net gains in the prior year period related to sales of its healthcare and specialized market businesses and the early extinguishment of debt as factors in the net income decrease.

2. 02

   Verisk said adjusted EBITDA for Q2 was $445 million, up 11.9% (up 9.7% on an OCC basis), and diluted adjusted EPS was $1.88, up 8.0%. Adjusted EBITDA margin was 57.6%, compared with 55.4% in the prior year period.

3. 03

   The company said net cash provided by operating activities for Q2 was $244.5 million and free cash flow was $188.7 million, up 22.6%. During the same quarter, it completed an Accelerated Share Repurchase program of $100 million, repurchasing 0.3 million shares.

4. 04

   Verisk said it completed the acquisition of SuranceBay on July 17, 2025 for $162.5 million in cash. The company also entered into a definitive agreement on July 29 to acquire AccuLynx for $2.35 billion in cash, subject to the satisfaction of customary closing conditions including regulatory approval.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.